The University of Southampton
University of Southampton Institutional Repository

The cost effectiveness of budesonide in severe asthmatics aged one to three years

The cost effectiveness of budesonide in severe asthmatics aged one to three years
The cost effectiveness of budesonide in severe asthmatics aged one to three years

The cost effectiveness of budesonide treatment was determined in a 6-month randomised, double blind, placebo controlled study of 40 asthmatic children aged one to three years with persistent asthma symptoms despite bronchodilator therapy. Budesonide produced a mean (± sd) of 62 (54) symptom-free days compared with 38 (36) for placebo. Direct costs were reduced with budesonide by fewer doctor consultations and fewer hospital admissions for shorter periods. Indirect cost benefits occurred through reductions in the days lost from work by parents and days lost from playgroup by the child because of asthma. Total costs/patient/year for a budesonide- and placebo-treated child were £1397.83 and £1891.43, respectively. The marginal cost effectiveness ratio was -£6.33 in favour of budesonide. Budesonide effectively reduces asthma symptoms compared to placebo and the additional drug costs are substantially offset by a reduced use of healthcare services and reduced indirect costs to childrens' families.

Asthma, Budesonide, Children, Cost effectiveness
0962-1423
127-134
Connett, G.J.
55d5676c-90d8-46bf-a508-62eded276516
Lenney, W.
6f3a5624-186a-4181-825e-41cc0adbc55f
McConchie, S.M.
1c72d082-c51f-4e76-96b0-ae34346a3e05
Connett, G.J.
55d5676c-90d8-46bf-a508-62eded276516
Lenney, W.
6f3a5624-186a-4181-825e-41cc0adbc55f
McConchie, S.M.
1c72d082-c51f-4e76-96b0-ae34346a3e05

Connett, G.J., Lenney, W. and McConchie, S.M. (1993) The cost effectiveness of budesonide in severe asthmatics aged one to three years. British Journal of Medical Economics, 6, 127-134.

Record type: Article

Abstract

The cost effectiveness of budesonide treatment was determined in a 6-month randomised, double blind, placebo controlled study of 40 asthmatic children aged one to three years with persistent asthma symptoms despite bronchodilator therapy. Budesonide produced a mean (± sd) of 62 (54) symptom-free days compared with 38 (36) for placebo. Direct costs were reduced with budesonide by fewer doctor consultations and fewer hospital admissions for shorter periods. Indirect cost benefits occurred through reductions in the days lost from work by parents and days lost from playgroup by the child because of asthma. Total costs/patient/year for a budesonide- and placebo-treated child were £1397.83 and £1891.43, respectively. The marginal cost effectiveness ratio was -£6.33 in favour of budesonide. Budesonide effectively reduces asthma symptoms compared to placebo and the additional drug costs are substantially offset by a reduced use of healthcare services and reduced indirect costs to childrens' families.

Full text not available from this repository.

More information

Published date: 1993
Keywords: Asthma, Budesonide, Children, Cost effectiveness

Identifiers

Local EPrints ID: 420674
URI: https://eprints.soton.ac.uk/id/eprint/420674
ISSN: 0962-1423
PURE UUID: 7358facb-b15a-4067-ab2d-9f203d18f192
ORCID for G.J. Connett: ORCID iD orcid.org/0000-0003-1310-3239

Catalogue record

Date deposited: 11 May 2018 16:30
Last modified: 14 Mar 2019 01:22

Export record

Contributors

Author: G.J. Connett ORCID iD
Author: W. Lenney
Author: S.M. McConchie

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×